MAZE insider trading — Maze Therapeutics, Inc.
Over the last 90 days, insiders at Maze Therapeutics, Inc. (MAZE) made 0 open-market purchases worth $0 and 8 open-market sales worth $1.14M, making them net sellers by $1.14M. The largest sale was by Coloma Jason V (Chief Executive Officer), who sold 11,227 shares for $297K on Sep 2, 2026.
Updated Oct 16, 2026.
Recent MAZE insider transactions
Every Form 4 filed by Maze Therapeutics, Inc. officers, directors and 10% owners in the last 90 days, newest first. P = open-market purchase, S = open-market sale; other codes are awards, option exercises, tax withholding or gifts.
| Trade date | Insider | Role | Type | Ownership | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Coloma Jason V | Chief Executive Officer | S · Sale · 10b5-1 | Indirect | 34,501 | $27.02 | $932K | Form 4 |
| Oct 1, 2026 | Bernstein Harold | President, R&D & CMO | M · Option exercise · 10b5-1 | Direct | 16,141 | $10.42 | $168K | Form 4 |
| Oct 1, 2026 | Bernstein Harold | President, R&D & CMO | S · Sale · 10b5-1 | Direct | 16,141 | $26.93 | $435K | Form 4 |
| Sep 29, 2026 | Dandekar Atul | CSBO | M · Option exercise · 10b5-1 | Direct | 7,500 | $10.42 | $78K | Form 4 |
| Sep 29, 2026 | Dandekar Atul | CSBO | S · Sale · 10b5-1 | Direct | 7,500 | $27.06 | $203K | Form 4 |
| Sep 4, 2026 | Bernstein Harold | President, R&D & CMO | S · Sale · 10b5-1 | Direct | 9,705 | $26.22 | $255K | Form 4 |
| Sep 3, 2026 | Courtney Phillips | GC and Corp. Secretary | S · Sale | Direct | 2,012 | $26.01 | $52K | Form 4 |
| Sep 2, 2026 | Courtney Phillips | GC and Corp. Secretary | S · Sale | Direct | 1,981 | $26.47 | $52K | Form 4 |
| Sep 3, 2026 | Dandekar Atul | CSBO | S · Sale | Direct | 3,243 | $26.01 | $84K | Form 4 |
| Sep 2, 2026 | Dandekar Atul | CSBO | S · Sale | Direct | 3,191 | $26.47 | $84K | Form 4 |
| Sep 3, 2026 | Coloma Jason V | Chief Executive Officer | S · Sale | Direct | 11,411 | $26.01 | $297K | Form 4 |
| Sep 2, 2026 | Coloma Jason V | Chief Executive Officer | S · Sale | Direct | 11,227 | $26.47 | $297K | Form 4 |
| Sep 3, 2026 | Bernstein Harold | President, R&D & CMO | S · Sale | Direct | 5,189 | $26.01 | $135K | Form 4 |
| Sep 2, 2026 | Bernstein Harold | President, R&D & CMO | S · Sale | Direct | 5,106 | $26.47 | $135K | Form 4 |
| Sep 1, 2026 | Courtney Phillips | GC and Corp. Secretary | M · Option exercise | Direct | 11,000 | — | — | Form 4 |
| Sep 1, 2026 | Dandekar Atul | CSBO | M · Option exercise | Direct | 12,500 | — | — | Form 4 |
| Sep 1, 2026 | Coloma Jason V | Chief Executive Officer | S · Sale · 10b5-1 | Indirect | 34,501 | $26.29 | $907K | Form 4 |
| Sep 1, 2026 | Coloma Jason V | Chief Executive Officer | M · Option exercise · 10b5-1 | Direct | 50,000 | — | — | Form 4 |
| Sep 1, 2026 | Bernstein Harold | President, R&D & CMO | M · Option exercise · 10b5-1 | Direct | 36,141 | $10.42 | $168K | Form 4 |
| Sep 1, 2026 | Bernstein Harold | President, R&D & CMO | S · Sale · 10b5-1 | Direct | 16,141 | $26.36 | $426K | Form 4 |
| Aug 28, 2026 | Dandekar Atul | CSBO | M · Option exercise · 10b5-1 | Direct | 7,500 | $10.42 | $78K | Form 4 |
| Aug 28, 2026 | Dandekar Atul | CSBO | S · Sale · 10b5-1 | Direct | 7,500 | $27.58 | $207K | Form 4 |
| Aug 13, 2026 | Bernstein Harold | President, R&D & CMO | M · Option exercise · 10b5-1 | Direct | 16,142 | $10.42 | $168K | Form 4 |
| Aug 13, 2026 | Bernstein Harold | President, R&D & CMO | S · Sale · 10b5-1 | Direct | 16,142 | $27.61 | $446K | Form 4 |
| Aug 3, 2026 | Coloma Jason V | Chief Executive Officer | S · Sale · 10b5-1 | Indirect | 34,501 | $26.73 | $922K | Form 4 |
| Jul 29, 2026 | Dandekar Atul | CSBO | M · Option exercise · 10b5-1 | Direct | 7,500 | $10.42 | $78K | Form 4 |
| Jul 29, 2026 | Dandekar Atul | CSBO | S · Sale · 10b5-1 | Direct | 7,500 | $27.34 | $205K | Form 4 |
MAZE insider trading FAQ
Are insiders buying MAZE stock?
Not on the open market. In the last 90 days, Maze Therapeutics, Inc. insiders made no open-market purchases, and 8 open-market sales totaling $1.14M. Purchases with the insider's own money are generally seen as a stronger signal than sales, which happen for many reasons (taxes, diversification, planned 10b5-1 sales).
Who are the insiders trading MAZE?
Recent sellers: Bernstein Harold, Coloma Jason V, Courtney Phillips, Dandekar Atul.
Where does MAZE insider trading data come from?
Every transaction comes from SEC Form 4 filings on EDGAR. Company officers, directors and 10% owners must file a Form 4 within two business days of buying or selling. InsiderBolt reads these filings directly from the SEC.
More stocks with insider activity
Insider trading data is for informational purposes only and is not investment advice. Filings can be amended; always confirm details on SEC EDGAR.